Asensus Surgical, Inc.
ASXC · AMEX
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $9 | $7 | $8 | $3 |
| % Growth | 21% | -13.9% | 159.3% | – |
| Cost of Goods Sold | $13 | $11 | $11 | $5 |
| Gross Profit | -$5 | -$4 | -$3 | -$2 |
| % Margin | -53.4% | -53.4% | -34.8% | -62.7% |
| R&D Expenses | $37 | $29 | $19 | $17 |
| G&A Expenses | $19 | $20 | $19 | $14 |
| SG&A Expenses | $36 | $35 | $33 | $27 |
| Sales & Mktg Exp. | $17 | $15 | $13 | $13 |
| Other Operating Expenses | $0 | $8 | $11 | $11 |
| Operating Expenses | $73 | $72 | $63 | $55 |
| Operating Income | -$79 | -$76 | -$65 | -$60 |
| % Margin | -926.5% | -1,067.9% | -785% | -1,902% |
| Other Income/Exp. Net | $0 | $0 | $2 | -$0 |
| Pre-Tax Income | -$78 | -$75 | -$62 | -$61 |
| Tax Expense | $0 | $0 | $0 | -$2 |
| Net Income | -$78 | -$76 | -$62 | -$59 |
| % Margin | -914.5% | -1,066.2% | -758.8% | -1,868.1% |
| EPS | -0.31 | -0.32 | -0.28 | -0.85 |
| % Growth | 3.1% | -14.3% | 67.1% | – |
| EPS Diluted | -0.31 | -0.32 | -0.28 | -0.85 |
| Weighted Avg Shares Out | 250 | 236 | 227 | 71 |
| Weighted Avg Shares Out Dil | 250 | 236 | 227 | 71 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | $1 | $1 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $4 | $11 | $14 | $14 |
| EBITDA | -$74 | -$64 | -$48 | -$47 |
| % Margin | -867.4% | -907.1% | -580.1% | -1,483.8% |